Back to User profile » Dr Gary Bloomgren
Paper published by Dr Gary Bloomgren:
Original Research
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data
Bloomgren G, Sperling B, Cushing K, Wenten M
Therapeutics and Clinical Risk Management 2012, 8:313-321
Published Date: 20 June 2012